Daré Bioscience, Inc. (DARE) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Daré Bioscience, Inc. (DARE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $22.2M, listed on NASDAQ, employing roughly 21 people, carrying a beta of 1.09 to the broader market. Daré Bioscience, Inc. Led by Sabrina Martucci Johnson, public since 2014-04-10.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for DARE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →